NJ State Employees Deferred Compensation Plan’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,000
Closed -$226K 447
2025
Q1
$226K Hold
2,000
0.03% 389
2024
Q4
$211K Hold
2,000
0.03% 416
2024
Q3
$216K Hold
2,000
0.03% 423
2024
Q2
$217K Hold
2,000
0.03% 408
2024
Q1
$264K Hold
2,000
0.03% 391
2023
Q4
$243K Hold
2,000
0.03% 406
2023
Q3
$224K Hold
2,000
0.03% 404
2023
Q2
$291K Hold
2,000
0.04% 377
2023
Q1
$258K Hold
2,000
0.04% 402
2022
Q4
$255K Hold
2,000
0.04% 388
2022
Q3
$209K Hold
2,000
0.04% 406
2022
Q2
$210K Hold
2,000
0.03% 419
2022
Q1
$256K Sell
2,000
-60
-3% -$7.23K 0.03% 422
2021
Q4
$254K Hold
2,060
0.03% 435
2021
Q3
$293K Hold
2,060
0.04% 405
2021
Q2
$322K Hold
2,060
0.04% 399
2021
Q1
$320K Hold
2,060
0.05% 389
2020
Q4
$308K Hold
2,060
0.05% 373
2020
Q3
$272K Hold
2,060
0.05% 352
2020
Q2
$239K Buy
+2,060
New +$237K 0.04% 374

Other funds holding ZBH

NJ State Employees Deferred Compensation Plan's ZBH Position: Q2 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 2,000 shares — an estimated $226K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ZBH in Q2 2020 and held it in 20 quarters. The position peaked at $322K in Q2 2021. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • NJ State Employees Deferred Compensation Plan reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 2,000 Zimmer Biomet shares in Q2 2025, an estimated $226K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Zimmer Biomet in Q2 2020 and held it in 20 quarters.
  • NJ State Employees Deferred Compensation Plan's Zimmer Biomet position peaked at $322K in Q2 2021.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2025, filed 5 Aug 2025.